these data suggest that the decrease in renal function caused by sulphinpyrazone early after myocardial infarction could be mediated by an inhibition of renal prostaglandin and/or kallikrein-kinin synthesis .
C0038742
sulphinpyrazone
C0027051
myocardial infarction